Browsing Dahili Tıp Bilimleri / Internal Medıcal Scıences by Author "Tanyeri, P; Buyukokuroglu, ME; Mutlu, O; Ulak, G; Akar, FY; Celikyurt, IK; Erden, BF;"

Now showing items 1-3 of 3

Effects of ziprasidone, SCH23390 and SB277011 on spatial memory in the Morris water maze test in naive and MK-801 treated mice

Tanyeri, Pelin; Büyükokuroğlu, Mehmet Emin; Oguz Mutlu; Guner Ulak; Furuzan Yildiz Akar; Ipek Komsuoglu Celikyurt; Bekir Faruk Erden (PERGAMON-ELSEVIER SCIENCE LTD, 2015)

Conclusions: The second-generation antipsychotic drug ziprasidone and D1 antagonist SCH23390, but not the D3 antagonist SB277011, might be clinically useful for the treatment of cognitive impairments in patients with ...
Evidence that the anxiolytic-like effects of the beta3 receptor agonist Amibegron involve serotoninergic receptor activity

Tanyeri, Pelin; Büyükokuroğlu, Mehmet Emin (PERGAMON-ELSEVIER SCIENCE LTD, 2013)

Anxiety disorders are the most common behavioral disorders, and they exhibit high comorbidity rates. The aim of the present study was to confirm the effects of Amibegron, the first selective beta 3 adrenergic agent, on ...
Involvement of serotonin receptor subtypes in the antidepressant-like effect of beta receptor agonist Amibegron (SR 58611A): An experimental study

Tanyeri, Pelin; Büyükokuroğlu, Mehmet Emin (PERGAMON-ELSEVIER SCIENCE LTD, 2013)

New therapeutic strategies against depression, with less side effects and thus greater efficacy in larger proportion of depressed patients, are needed. Amibegron (SR58611A) is the first selective beta 3 adrenergic agent ...